The Prix Galien internationally stands as the industry equivalent of the Nobel Prize in medical innovation.
Initially, the award originated in France, but thanks to the growing dedication of numerous companies to biomedical research and development, this esteemed prize is now granted in 15 different countries.
In Belgium, Artsenkrant/Le Journal du Médecin is the driving force behind the Prix Galien propelling innovation in the Belgian healthcare sector!
Would you like to send in your application for the Prix Galien 2024? You can now submit your ‘intention to participate’ for the pharmaceutical & pharmacology prize by clicking on the button below:
THE PRIZE IS PRESENTED IN FOUR DISTINCT CATEGORIES:
Medical Devices
The most innovative medical device, honours a medical device that can lead to better treatment
The most promising design, dedicated to a young company showcasing an innovative product
Pharmaceuticals
The best pharmaceutical agent, reserved for the most groundbreaking pharmaceutical innovation.
The best pharmacological research project, acknowledging the contributions of a researcher or a group of researchers in the realm of clinical studies and/or fundamental research.